The synergistic effects of GLP-1 analogs combined with estradiol conjugates are promising
Educational information only not medical advice
Tirzepatide is a dual GLP-1 and GIP receptor agonist that reduces appetite and improves insulin sensitivity, making it effective for weight loss and blood sugar control
But know that dose modification is a legitimate tool for managing side effects, and a good provider will work with you to find the balance between therapeutic benefit and tolerability
Rising demand for noninvasive and patient-friendly treatment options boosts the growth

Obesity pathophysiology and metabolic science: Understanding the hormonal, neurological, and genetic factors that drive weight gain and resist weight loss GLP-1 receptor agonist mastery: Comprehensive training on semaglutide, tirzepatide, and emerging agents, including prescribing protocols, titration schedules, contraindication screening, and side effect management Comprehensive pharmacotherapy: Phentermine, phentermine-topiramate, naltrexone-bupropion, orlistat, metformin, and combination strategies Peptide therapy and compounded medications: Navigating the regulatory and clinical landscape for compounded semaglutide and adjunctive peptides Metabolic testing and body composition analysis: Hands-on training with indirect calorimetry, DEXA scanning, and bioimpedance analysis Nutritional programming: Developing individualized meal plans, protein optimization for lean mass preservation, and supplement protocols Behavioral health integration: Practical CBT and motivational interviewing techniques for the clinical weight management setting Business and practice operations: Program pricing, patient acquisition, billing and coding, staff training, and scaling strategies Why AAOPM The AAOPM approach to medical weight loss certification is distinguished by its emphasis on immediate clinical applicability
